Health news and commentary gathered by MedPage Today staff ...
Hydroxychloroquine (HCQ) is the backbone of therapy for most patients with systemic lupus erythematosus, but patient ...
DESTIN, Fla. — The anticipated FDA approval of brepocitinib signals an important shift in dermatomyositis management, according to a speaker at the Congress of Clinical Rheumatology East. A ...
BSR 2026 Four Factors Keep ‘At-Risk’ Group Arthritis-Free at 10 Years People with ‘good’ prognostic factors at baseline are less likely to progress to rheumatoid arthritis at 5 and 10 years after ...
The biggest stories of the day delivered to your inbox.